SCHEMBL5770320

SCHEMBL5770320

O=C1[C@H]2CNC[C@H]2C(=O)N1Cc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.69
KMT2A Q03164 3/20 0.59
MEN1 O00255 2/20 0.59
TSHR P16473 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
F2 P00734 1/20 0.53
PLG P00747 1/20 0.53
ELANE P08246 1/20 0.53
CTSG P08311 1/20 0.53
CMA1 P23946 1/20 0.53
CTRC Q99895 1/20 0.53
GSK3A P49840 2/20 0.51
GSK3B P49841 2/20 0.51
EP300 Q09472 2/20 0.50
MAPK1 P28482 2/20 0.50
ACHE P22303 1/20 0.50
MGLL Q99685 1/20 0.50
CYP2C9 P11712 1/20 0.49
MT-CO2 P00403 1/20 0.49
ALOX5 P09917 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584720 1.00 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL1749140 0.98 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL1749922 0.98 ALDH1A1 (0.67) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL651980 0.89 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL13783795 0.85 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL1023519 0.85 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL12372537 0.85 ALDH1A1 (0.73) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL8572187 0.82 MT-CO2 (0.54) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL8383162 0.81 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2
SCHEMBL6747735 0.81 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020100011-A1 IMPROVED SYNTHETIC METHODS OF MAKING FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-05-22 WO disclosed
EP-1732546-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS Aventis Pharma S.A. (FR) 2006-12-20 EP disclosed
WO-2005095399-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2005-10-13 WO disclosed